amikacin has been researched along with Lymphohistiocytosis, Hemophagocytic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baldovino Chiquillo, L; Leal, DD; Rico, DL; Romero, M | 1 |
| Gotoh, M; Katagiri, S; Nakamura, I; Ohyashiki, K; Yoshizawa, S | 1 |
| Fujii, H; Goto, H; Ikezawa, Z; Inayama, Y; Ito, S; Kajiwara, R; Kuroki, F; Shigehira, Y; Taniguchi, A; Yanagimachi, M; Yokosuka, T; Yokota, S | 1 |
3 other study(ies) available for amikacin and Lymphohistiocytosis, Hemophagocytic
| Article | Year |
|---|---|
Haemophagocytic syndrome caused by disseminated nontuberculous mycobacterial infection.
Topics: Amikacin; Ciprofloxacin; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Mycobacterium Infections, Nontuberculous; Opportunistic Infections | 2023 |
[Case report; Disseminated Mycobacterium abscessus infection with hemophagocytic syndrome during treatment of chronic lymphocytic leukemia].
Topics: Amikacin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Clarithromycin; Cyclophosphamide; Humans; Imipenem; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Levofloxacin; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Prednisolone; Treatment Outcome | 2014 |
[Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation].
Topics: Amikacin; Anti-Bacterial Agents; Child, Preschool; Clarithromycin; Cord Blood Stem Cell Transplantation; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Lymphohistiocytosis, Hemophagocytic; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Treatment Outcome | 2008 |